A investigator initiated phase II proof of concept trial of RS5614 for treatment of chronic myeloid leukaemia
Latest Information Update: 22 Feb 2024
At a glance
- Drugs RS 5614 (Primary)
- Indications Chronic myeloid leukaemia
- Focus Proof of concept; Therapeutic Use
Most Recent Events
- 22 Feb 2024 New trial record